{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361137044915420800.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/j.ijpharm.2008.02.011"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0378517308001257?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0378517308001257?httpAccept=text/plain"}}],"dc:title":[{"@value":"Inhaled nanoparticles—A current review"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1381137044915420802","@type":"Researcher","foaf:name":[{"@value":"Wei Yang"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137044915420800","@type":"Researcher","foaf:name":[{"@value":"Jay I. Peters"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137044915420801","@type":"Researcher","foaf:name":[{"@value":"Robert O. Williams"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"03785173"}],"prism:publicationName":[{"@value":"International Journal of Pharmaceutics"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2008-05","prism:volume":"356","prism:number":"1-2","prism:startingPage":"239","prism:endingPage":"247"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S0378517308001257?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S0378517308001257?httpAccept=text/plain"}],"createdAt":"2008-02-20","modifiedAt":"2019-05-08","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360004230319205120","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Use of nanoparticles to deliver immunomodulatory oligonucleotides"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004232070975232","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Development of PEG–PLA/PLGA microparticles for pulmonary drug delivery prepared by a novel emulsification technique assisted with amphiphilic block copolymers"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004232532501632","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Purinergic signaling via P2X7 receptor mediates IL-1β production in Kupffer cells exposed to silica nanoparticle"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283694088337664","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Interaction of Silica Nanoparticles with Phospholipid Membranes"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285707181629952","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Nanoparticles of glycol chitosan and its thiolated derivative significantly improved the pulmonary delivery of calcitonin"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567182484539776","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Silica nanoparticles activate purinergic signaling via P2X 7 receptor in dendritic cells, leading to production of pro-inflammatory cytokines"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848657068210176","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Ultrastructural changes in the air–blood barrier in mice after intratracheal instillations of Asian sand dust and gold nanoparticles"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204641054720","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Nanotechnologies in development of pulmonary drug delivery"},{"@language":"ja","@value":"微粒子製剤による薬物経肺デリバリー　　ナノテクノロジーを利用した経肺投与技術の開発"},{"@value":"ナノテクノロジーを利用した経肺投与技術の開発"},{"@language":"ja-Kana","@value":"ナノテクノロジー オ リヨウ シタ ケイ ハイ トウヨ ギジュツ ノ カイハツ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205513354624","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Aerosol Delivery of siRNA to the Lungs. Part 1: Rationale for Gene Delivery Systems"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001206427723136","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Demonstration of the Clathrin- and Caveolin-Mediated Endocytosis at the          Maternal–Fetal Barrier in Mouse Placenta after Intravenous Administration of Gold          Nanoparticles"}]},{"@id":"https://cir.nii.ac.jp/crid/1390005822569562240","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Consideration of Metal Organic Frameworks for Respiratory Delivery"}]},{"@id":"https://cir.nii.ac.jp/crid/1523951031010154496","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Inhalable nanoparticles delivery targeting alveolar macrophages for the treatment of pulmonary tuberculosis"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/j.ijpharm.2008.02.011"},{"@type":"CROSSREF","@value":"10.1002/wnan.1382_references_DOI_FmrGyUBsXSDerr5u3HbziARMJJS"},{"@type":"CROSSREF","@value":"10.14356/kona.2016014_references_DOI_FmrGyUBsXSDerr5u3HbziARMJJS"},{"@type":"CROSSREF","@value":"10.1292/jvms.13-0512_references_DOI_FmrGyUBsXSDerr5u3HbziARMJJS"},{"@type":"CROSSREF","@value":"10.1016/j.tiv.2016.06.003_references_DOI_FmrGyUBsXSDerr5u3HbziARMJJS"},{"@type":"CROSSREF","@value":"10.1016/j.tox.2014.03.008_references_DOI_FmrGyUBsXSDerr5u3HbziARMJJS"},{"@type":"CROSSREF","@value":"10.1246/cl.2012.1322_references_DOI_FmrGyUBsXSDerr5u3HbziARMJJS"},{"@type":"CROSSREF","@value":"10.14356/kona.2021013_references_DOI_FmrGyUBsXSDerr5u3HbziARMJJS"},{"@type":"CROSSREF","@value":"10.2745/dds.24.477_references_DOI_FmrGyUBsXSDerr5u3HbziARMJJS"},{"@type":"CROSSREF","@value":"10.1016/j.ijpharm.2010.07.001_references_DOI_FmrGyUBsXSDerr5u3HbziARMJJS"},{"@type":"CROSSREF","@value":"10.1016/j.jbiosc.2021.08.009_references_DOI_FmrGyUBsXSDerr5u3HbziARMJJS"},{"@type":"CROSSREF","@value":"10.1016/j.colsurfb.2011.06.004_references_DOI_FmrGyUBsXSDerr5u3HbziARMJJS"},{"@type":"CROSSREF","@value":"10.1016/j.etp.2013.03.003_references_DOI_FmrGyUBsXSDerr5u3HbziARMJJS"}]}